|
02 Jul 2015 |
Social |
Ixekizumab (anti-IL17) is superior to Enbrel in 1224 pts w/ plaque psoriasis (UNCOVER-2) w/ rapid decr in itch scores http://t.co/ozZbHEq6Wu |
|
|
23 Oct 2016 |
Social |
Dr. Sergio Schwartzman comments on new Ocular Screening Guidlines for Hydroxychloroquine at RheumNow https://t.co/Qm1iDM77Jo |
|
|
27 Jul 2015 |
Social |
Having cholecystectomy-confirmed gallstones was assoc w/ risk of psoriasis (RR 2·20) & concomitant PsA (RR 4·41) http://t.co/xW9BuiTQHR |
|
|
04 Jan 2017 |
Social |
NICE recommends apremilast for use in psoriatic arthritis w/in UK NHS. Risk of suidical ideation is 0.2% (3/1441) https://t.co/ZFDSo3B81u |
|
|
08 Jun 2016 |
Social |
Secukinumab data presented at EULAR; Novartis plans H2H trial of Cosentyx & Humira; details to follow https://t.co/zjA8Rgw0cX |
|
|
17 Feb 2017 |
Social |
RT @DrRachelTate: Tofa as an option for AS? No FDA indication but a potential off label option. E. Ruderman MD #rwcs2017 @RWCSmtg @RheumNow… |
|
|
14 Jul 2016 |
Social |
in 428 SpA pts, BMI (obesity) has no effect on ASDAS. BMI weakly correlates w/ CRP, other PRO's. https://t.co/FcTfEicYpN |
|
|
11 Nov 2015 |
Social |
Dr Atul Deodhar on video at RheumNow, discussing new therapies for ankylosing splondylitis. Live from #ACR15 https://t.co/wJFcAurQYE |
|
|
28 Mar 2017 |
Social |
RT @CBSHealth: FDA approves powerful new drug for eczema -- but it comes with a hefty price tag https://t.co/EOjOgCdoci https://t.co/V49wgh… |
|
|
15 Sep 2016 |
Social |
RT @RonanTKavanagh: patients with psoriatic spondyloarthritis more steroid responsive than patients with Ank Spond (60% vs 20% at week 2. #… |
|
|
08 Feb 2016 |
Social |
Acute sacroiliitis Dx by bone or CT scan. Causes include pyogenic infx, brucellosis, crystal induced, neoplasia https://t.co/toLl8suM0i |
|
|
18 Feb 2016 |
Social |
IL-36 is an important mediator of bowel inflammation in mouse model of IBD, Blocking IL-36 improves the IBD https://t.co/Cr3bSsDIJk |
|
|
10 Jul 2015 |
Social |
Algorithmic approach to the diagnosis of Heel Pain based on pain location, quality from AFP http://t.co/kWiWMF5bgF http://t.co/3kgR5H9CZl |
|
|
17 Nov 2016 |
Social |
RT @HealioRheum: Guselkumab found safe and effective for treatment of psoriatic arthritis https://t.co/fcjn3Rcdcd #ACR16 |
|
|
02 May 2016 |
Social |
Health Canada approves secukinumab for use in psoriatic arthritis and anklylosing spondylitis https://t.co/TmmJyBXf24 |
|
|
21 Jan 2017 |
Social |
What you need to know about management of axial SpA:the 2016 update of the ASAS-EULAR recommendations @DrPetryna https://t.co/E4YSqbBG83 |
|
|
12 May 2015 |
Social |
Reveille writes no biomarker has reproducibly shown to assess Dz activity or predict outcome; remains an unmet need http://t.co/jTZDCluiky |
|
|
07 Dec 2015 |
Social |
Metformin decreases TH17 cells & IL-22; new study shows it also transforms microbiome in Type 2 diabetes https://t.co/13FFmvKjeQ |
|
|
21 Apr 2017 |
Social |
Valeant prices new Psoriasis drug Siliq (brodalumab) at $42,000/yr. undercutting price of other IL-17 drugs. https://t.co/mfu0ZWWkvv |
|
|
07 May 2017 |
Social |
Pfizer submitted tofacitinib NDA to FDA for psoriatic arthritis. FDA prev denied the NDA for psoriasis w/ CR letter. https://t.co/1EMk9QsW3V |
|
